Baidu Announces Dual-Primary Listing on the Main Board of The Stock Exchange of Hong Kong Limited

NEWS PROVIDED BY

Baidu, Inc.

Aug 31, 2026, 20:00 ET

SHARE THIS ARTICLE

BEIJING, Aug. 31, 2026 /PRNewswire/ -- Baidu, Inc. ("Baidu" or the "Company") (Nasdaq: BIDU; HKEX: 9888 (HKD Counter) and 89888 (RMB Counter)), a leading AI company with strong Internet foundation, today announced that the Company's voluntary conversion of its secondary listing status to dual-primary listing on the Main Board of The Stock Exchange of Hong Kong Limited (the "Hong Kong Stock Exchange") became effective today. Baidu is now a dual-primary listed company on the Hong Kong Stock Exchange in Hong Kong SAR and the Nasdaq Global Select Market in the United States.

The Company's ordinary shares listed on the Hong Kong Stock Exchange and the Company's American depositary shares listed on the Nasdaq Global Select Market will continue to be fungible.

About Baidu

Founded in 2000, Baidu's mission is to make the complicated world simpler through technology. Baidu is a leading AI company with strong Internet foundation, trading on Nasdaq under "BIDU" and HKEX under "9888". One Baidu ADS represents eight Class A ordinary shares.

Safe Harbor Statement

This announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," "confident" and similar statements. Among other things, Baidu's and other parties' strategic and operational plans, contain forward-looking statements. Baidu may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission, in announcements made on the website of the Hong Kong Stock Exchange, in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including but not limited to statements about Baidu's beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: Baidu's growth strategies; its future business development, including development of new products and services; its ability to attract and retain users and customers; competition in the Chinese Internet search and newsfeed market; competition for online marketing customers; changes in the Company's revenues and certain cost or expense items as a percentage of its revenues; the outcome of ongoing, or any future, litigation or arbitration, including those relating to intellectual property rights; the expected growth of the Chinese-language Internet search and newsfeed market and the number of Internet and broadband users in China; Chinese governmental policies relating to the Internet and Internet search providers, and general economic conditions in China and elsewhere. Further information regarding these and other risks is included in the Company's annual report on Form 20-F and other documents filed with the Securities and Exchange Commission, and announcements on the website of the Hong Kong Stock Exchange. Baidu does not undertake any obligation to update any forward-looking statement, except as required under applicable law. All information provided in this press release and in the attachments is as of the date of the press release, and Baidu undertakes no duty to update such information, except as required under applicable law.

SOURCE Baidu, Inc.

21%

more press release views with 

Request a Demo

31.08.2026 – 23:34

SPORT BILD

SPORT BILD-Award 2026: Die größten Sportstars des Jahres geehrt

"Wer ihn kennt, der mag ihn": Kabarettist Bruno Jonas hält Laudatio auf "Legende" Uli Hoeneß

Bild-Infos Download

Hamburg (ots)

Das war eine Nacht der großen Emotionen, der starken Geschichten und der außergewöhnlichen Leistungen. Bei der Verleihung des SPORT BILD-Awards 2026 in Hamburg wurden am Montagabend, 31. August 2026, die herausragenden Persönlichkeiten, Teams und Initiativen des Sportjahres ausgezeichnet. Erstmals führte TV-Moderatorin Esther Sedlaczek zusammen mit SPORT BILD-Chefredakteur Henning Feindt durch den Abend.

Im Mittelpunkt standen sportliche Höchstleistungen, bewegende Comebacks und beeindruckendes gesellschaftliches Engagement. Vor rund 700 Gästen aus Sport, Politik, Wirtschaft und Medien wurden die Gewinnerinnen und Gewinner in der Hamburger Fischauktionshalle in insgesamt zehn Kategorien geehrt:

Uli Hoeneß ist die Legende

Mit dem Legenden-Award wurde Bayern-Ehrenpräsident Uli Hoeneß für sein einzigartiges Lebenswerk ausgezeichnet. Als Spieler und Funktionär gewann der gebürtige Ulmer insgesamt 48 Titel, darunter die Europameisterschaft 1972 und die Weltmeisterschaft 1974 mit der deutschen Nationalmannschaft. 1979 übernahm Hoeneß im Alter von nur 27 Jahren die Rolle des Managers beim damals verschuldeten FC Bayern München und entwickelte den Klub in den folgenden Jahrzehnten zu einer der größten Sportmarken der Welt. Später war er Präsident und Aufsichtsratsvorsitzender des Rekordmeisters.

Die Laudatio hielt Kabarettist Bruno Jonas, der seit vielen Jahren eng mit Hoeneß verbunden ist. Er hob die "feindosierte Impulskontrolle" eines Heiligen von heute hervor: "Die Wahrheit wohnt am Tegernsee". Uli Hoeneß zeigte sich als Legende, aber noch lange nicht am Ende: "Mein Hunger ist immer noch da. Ich liebe Menschen, die hungrig sind."

Aufsteiger des Jahres ist FC Schalke 04

Der FC Schalke 04 ist zurück in der ersten Fußball-Bundesliga. Nach drei Jahren Zweitklassigkeit kehrte der Traditionsverein aus dem Revier ins Oberhaus zurück und begeisterte seine Fans mit einem unvergesslichen Aufstieg. Der 1:0-Sieg im entscheidenden Heimspiel am 32. Spieltag gegen Fortuna Düsseldorf löste unfassbare Emotionen und Euphorie aus. Stellvertretend für den Verein nahmen Trainer Miron Muslic, Sportdirektor Youri Mulder und Torwart Loris Karius die Auszeichnung entgegen.

Einfach Gold: Olympia-Award für Julia Taubitz

Olympisches Gold nach einem dramatischen Rückschlag: Julia Taubitz wurde mit dem Olympia-Award ausgezeichnet. Nachdem sie bei den Spielen 2022 in Peking im Eiskanal gestürzt war, gelang ihr vier Jahre später in Cortina d'Ampezzo das beeindruckende Comeback. Die Rennrodlerin gewann Gold im Einzel sowie mit der deutschen Teamstaffel und begeisterte darüber hinaus mit ihrer sympathischen und authentischen Art.

Rule the Darts: Weltmeister-Award geht an Luke Littler

Darts-Sensation Luke Littler erhielt den Weltmeister-Award. Der 19-jährige Engländer ist der jüngste Weltmeister der Geschichte seines Sports. Nach seinem ersten Triumph im Londoner Alexandra Palace 2025 verteidigte er den Titel 2026 eindrucksvoll. "Luke the Nuke" dominiert die Darts-Welt wie kaum ein Spieler zuvor. Zudem knackte er als erster Darts-Profi die Marke von einer Million Followern auf Instagram.

Großer Aufschlag: Star des Jahres ist Alexander Zverev

Der Titel "Star des Jahres" ging an Tennis-Profi Alexander Zverev. Der Hamburger erfüllte sich 2026 seinen größten Traum und gewann bei den French Open sein erstes Grand-Slam-Turnier. "Darauf habe ich mein ganzes Leben hingearbeitet", sagte Zverev im Video mit einem sichtlich stolzen Hamburger Innensenator Andy Grote. Da der Weltranglistenspieler parallel bei den US Open in New York im Einsatz ist, konnte er die Auszeichnung nicht persönlich entgegennehmen.

Für ein Miteinander: Allinclusion Sports erhält Kids-Charity-Award by Hagedorn:

Mit dem Kids-Charity-Award wurde Tobias Gemein vom Verein Allinclusion Sports für sein beispielhaftes gesellschaftliches Engagement geehrt. Der erste inklusive Indoor-Sportverein in Bonn und Köln bringt Kinder mit und ohne Einschränkungen gemeinsam in Bewegung. Das Motto der Initiative lautet: "Miteinander statt nebeneinander" und "Erlebnis statt Ergebnis". Die Auszeichnung nahm seine Mutter Sandra Gemein mit emotionalen Worten entgegen. Der Preis in Höhe von 50.000 Euro wurde von der Thomas Hagedorn Stiftung gespendet.

Der Torjäger: Harry Kane ist Fußballstar des Jahres:

Der Preis als Fußballstar des Jahres ging an Harry Kane. Mit unglaublichen 61 Pflichtspieltoren in lediglich 51 Partien schrieb der englische Nationalspieler Sportgeschichte. In der Bundesliga erzielte Kane 36 Treffer und sicherte sich zum dritten Mal in Folge die Torjägerkanone - ein bislang einmaliger Erfolg. Auch im DFB-Pokalfinale glänzte Kane mit einer herausragenden Leistung. Bei der Weltmeisterschaft führte er England als Kapitän zu Platz drei und steuerte sechs Turniertore bei.

Sonderpreis der Chefredaktion: Leo Neugebauer ist "König der Athleten"

Den Sonderpreis der Chefredaktion erhielt Zehnkämpfer Leo Neugebauer. Nach seinem WM-Triumph 2025 bestätigte der Ausnahmeathlet seine Weltklasse auch 2026 und gewann die Europameisterschaft in Birmingham. Besonders dramatisch verlief der abschließende 1500-Meter-Lauf, in dem Neugebauer mit letzter Kraft seinen Vorsprung vor Niklas Kaul verteidigte. Der Deutsche steht damit wie kaum ein anderer für Konstanz auf höchstem Niveau und darf sich zurecht "König der Athleten" nennen.

Gut verbunden: TV-Award für MagentaTV und Überraschungs-Award für Johannes B. Kerner

Der TV-Award ging an MagentaTV für die herausragende Berichterstattung von der Fußball-Weltmeisterschaft in den USA, Kanada und Mexiko. Mit der Übertragung aller 104 WM-Spiele überzeugte der Sender nicht nur durch Umfang, sondern auch durch Qualität, kompetente Analysen und große Unterhaltung. Stellvertretend nahmen den SPORT BILD-Award 2026 Laura Wontorra, Wolff Fuss, Arnim Butzen, Tabea Kemme sowie Johannes B. Kerner entgegen, der von SPORT BILD-Chefredakteur Henning Feindt außerdem einen persönlichen Überraschungs-Award dafür erhielt, wie er die Sportmoderation im Fernsehen seit 20 Jahren neu definiert hat.

Henning Feindt, Chefredakteur SPORT BILD: "Diese Preisträger haben Deutschland und die Sportwelt begeistert. Sie haben Rekorde gebrochen, Titel gewonnen, Rückschläge überwunden und Millionen Menschen mitgerissen. Genau solche Geschichten machen Sport so besonders. Der SPORT BILD-Award zeichnet nicht nur Erfolge aus, sondern vor allem Menschen, die Fans berühren und inspirieren."

Zu den Gästen des SPORT BILD-Awards 2026 zählten unter anderem FC-Bayern-Präsident Herbert Hainer, Red-Bull-Geschäftsführer Oliver Mintzlaff, DFB-Präsident Bernd Neuendorf, OMR-Chef Philipp Westermeyer, die italienische TV-Moderatorin Diletta Leotta, die TV-Moderatoren Alexander Bommes und Florian König, Fußball-Experte Marcel Reif, Olympiasiegerin Gina Lückenkemper, Handball-Legende Stefan Kretzschmar sowie BVB-Geschäftsführer Lars Ricken sowie zahlreiche weitere Persönlichkeiten aus Sport, Medien, Wirtschaft und Gesellschaft.

Mit dem SPORT BILD-Award zeichnet Europas größtes Sportmagazin seit 2003 Persönlichkeiten, Teams und Momente aus, die das Sportjahr in besonderer Weise geprägt haben. Die Auszeichnungen zählen zu den renommiertesten Ehrungen im deutschen Sport.

Pressekontakt:

Christian Senft

Director Communications BILD-Gruppe

E-Mail: christian.senft@axelspringer.com

Mobil: +49 151 440 47239

Original-Content von: SPORT BILD, übermittelt durch news aktuell

PTFE Membranes Market worth $2.84 billion by 2031 - Exclusive Report by MarketsandMarkets™

NEWS PROVIDED BY

MarketsandMarkets

Aug 31, 2026, 18:40 ET

SHARE THIS ARTICLE

DELRAY BEACH, Fla., Aug. 31, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the PTFE Membranes Market is expected to reach USD 2.84 billion by 2031 from USD 2.14 billion in 2026, at a CAGR of 5.8 % during the forecast period.  

Browse 260 market data Tables and 60 Figures spread through 330 Pages and in-depth TOC on "PTFE Membranes Market - Global Forecast to 2031"

PTFE Membranes Market Size & Forecast:

Market Size Available for Years: 2025-2031

2026 Market Size: USD 2.14 billion

2031 Projected Market Size: USD 2.84 billion

CAGR (2026-2031): 5.8%

PTFE Membranes Market Trends & Insights:

The global PTFE membranes market is experiencing regional growth, driven by rising demand for high-performance filtration, expanding pharmaceutical and biotechnology activities, and increasing deployment of advanced membrane technologies across industrial and critical applications. Asia Pacific is the largest regional market, supported by rapid industrialization, infrastructure development, expanding pharmaceutical and electronics manufacturing, and increasing demand for advanced filtration across China, India, Japan, South Korea, and Southeast Asia. North America holds the second-largest share, supported by pharmaceutical and biotechnology production, semiconductor manufacturing, healthcare facilities, water treatment, and stringent filtration and environmental requirements. Europe is supported by demand for high-purity filtration across pharmaceutical, industrial, healthcare, and water treatment applications. Meanwhile, South America and the Middle East & Africa are experiencing growing demand, driven by industrialization, water and wastewater treatment, healthcare infrastructure, pharmaceutical production, and increasing adoption of advanced filtration technologies across emerging markets.

By region, the Asia Pacific PTFE membranes market accounted for 42.2% of the market in 2026, driven by rapid industrialization, expanding pharmaceutical and biotechnology manufacturing, growing semiconductor and electronics production, and increasing demand for advanced filtration solutions across the region.

By type, the hydrophobic segment dominated the PTFE membranes market in 2026, accounting for 66.7% of the overall market value, owing to its high chemical resistance, hydrophobicity, and widespread use in air, gas, and liquid filtration applications.

By technology, the microfiltration segment dominated the PTFE membranes market in 2026, accounting for 45.8% of the overall market in terms of value, owing to its high filtration efficiency, broad particle-removal capability, and extensive use across industrial, pharmaceutical, and water treatment applications.

By form, the spiral segment accounted for the highest share (44.8%) of value in 2026, owing to its compact configuration, high membrane area, and widespread use in industrial and water filtration applications.

By application, the food & beverage application segment accounted for the largest share (22.2%) of the PTFE membranes market in terms of value in 2026, owing to increasing demand for high-purity filtration, contamination control, and reliable processing solutions.

W. L. Gore & Associates, Inc. and Merck KGaA were identified as some of the star players in the PTFE membranes market (global), given their strong market share and product footprint.

Agilent Technologies, Inc., Sterlitech Corporation, and Zeus Company LLC have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas, underscoring their potential as emerging market leaders.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=243714287 

The expansion of the PTFE membranes market is driven by increasing demand for high-performance filtration, separation, and protective products across industries such as industrial, commercial, healthcare, automotive, electronics, construction, and infrastructure. PTFE membranes are known for their exceptional properties, including chemical resistance, low friction, high filtration efficiency, and durability, making them suitable for a wide range of harsh environments. Additionally, stringent environmental regulatory guidelines, a heightened need for clean water and air, growth in pharmaceutical and biotechnology production, and the adoption of more advanced industrial methods are significant factors driving the market's growth.

Moreover, advancements in membrane manufacturing processes have enabled the production of PTFE membranes with enhanced permeability, superior filtration performance, finer pore structures, extended lifespans, and consistent performance, even under challenging conditions. As a result, high-quality PTFE membrane technology has become an essential component of modern filtration and separation processes, helping to protect the environment while facilitating industrial operations.

The hydrophilic segment is expected to be the fastest-growing segment, by type, during the forecast period.

Hydrophilic PTFE membranes are expected to be the fastest-growing segment in the PTFE membranes market.is growth is primarily due to their excellent wettability, high chemical resistance, and ability to function effectively as liquid filtration devices. These membranes are designed to allow easy filtration of aqueous solutions while preventing the passage of particles and contaminants. Hydrophilic PTFE membranes are widely used across industries, including pharmaceuticals, biotechnology processing, water and wastewater treatment, food and beverage production, chemical processing, and other liquid filtration systems. The increasing adoption of these membranes in industry is driven by rising purity requirements in liquid filtration and sterilization processes, as well as a growing demand for effective treatment solutions. Moreover, their compatibility with both aqueous and organic solvents, combined with reliable performance in harsh working conditions, has contributed to their popularity across various end-use applications.

The microfiltration segment is expected to be the fastest-growing technology segment during the forecast period.

During the forecast period, microfiltration is anticipated to be the fastest-growing technology in the PTFE membranes industry. This growth is primarily driven by its high filtration efficiency, straightforward operation, and effective removal of suspended particles, microorganisms, and other impurities from liquids and gases. Microfiltration-based PTFE membranes are widely used in various sectors, including pharmaceutical and biotechnology processing, water and wastewater treatment, food and beverage processing, semiconductor processing, and industrial filtration applications. The increasing demand for high-purity filtration, contamination control, and efficient treatment processes is creating opportunities for microfiltration applications. Additionally, rising investment in water treatment plants and pharmaceutical manufacturing is boosting demand for microfiltration-based PTFE membrane technology across numerous end-use industries.

The spiral segment is expected to be the fastest-growing segment, by form, during the forecast period.

Spiral Membranes are anticipated to be the fastest-growing segment in the PTFE Membranes market. This growth is largely attributed to their compact design, large surface area, and efficient filtration capabilities. Spiral membranes provide higher filtration efficiency within a smaller footprint, making them ideal for applications where space, throughput efficiency, and time are critical. These membranes are rapidly finding applications in various sectors, including water and wastewater treatment, pharmaceutical and biotechnology processing, food and beverage, chemical processing, and industrial filtration. The ongoing demand for compact, highly efficient filtration systems, along with growing investments in advanced water treatment and industrial technologies, is driving the adoption of spiral PTFE membrane configurations across diverse end-use applications.

Inquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=243714287 

The food & beverage segment is expected to be the fastest-growing application segment during the forecast period.

The food & beverage sector is anticipated to be the fastest growing application in the PTFE membranes market. This growth is primarily attributed to the membranes' high-purity filtration, contamination control, and reliable processing solutions. PTFE membranes are widely used in liquid and gas filtration, clarification, sterile processing, and venting applications in dairy, beverage, brewing, and food processing operations. The increasing emphasis on food safety, product quality, process efficiency, and hygienic manufacturing practices makes PTFE membrane solutions particularly attractive. Additionally, the market is expected to grow due to expansion in food & beverage production and rising investment in the development of advanced filtration systems.

The Asia Pacific is expected to be the fastest-growing region during the forecast period.

The PTFE membranes market in the Asia Pacific region is expected to be the fastest growing from 2026 to 2031. This growth is driven by rapid industrialization, urbanization, manufacturing expansion, and significant investments in the pharmaceutical, biotechnology, semiconductor, electronics, and water treatment sectors. Countries such as China, India, Japan, South Korea, and various economies in Southeast Asia are increasing their industrial and manufacturing activities, which in turn boosts the demand for efficient filtration systems. Areas such as pharmaceuticals, semiconductor manufacturing, food and beverage processing, chemical industries, and water and wastewater treatment are increasingly utilizing PTFE membranes. Additionally, there is a rising demand for high-purity filtration, effective contamination control, chemical resistance, and reliable membrane performance, all of which are creating growth opportunities for the PTFE membranes market in the Asia Pacific region.

As industrialization and manufacturing continue to expand rapidly in this region, countries like China, India, Japan, and South Korea are making substantial investments in advanced manufacturing, healthcare infrastructure, digital technologies, and industrial development. These nations are also increasing their capacity for water and wastewater treatment and enhancing critical industrial and healthcare facilities, which further drives the need for high-quality filtration solutions. The growing demand for efficient contamination control, high-purity processing, chemical resistance, and reliable filtration performance is driving greater adoption of advanced PTFE membrane technologies. Consequently, the Asia Pacific region is poised to achieve the highest growth potential during the forecast period.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=243714287 

Key Players

The report profiles several key PTFE membranes companies, including Pall Corporation (US), Cytiva (US), W. L. Gore & Associates, Inc. (US), Merck KGaA (US), Corning Incorporated (US), Donaldson Company, Inc. (US), Saint-Gobain (France), Sartorius AG (Germany), HYUNDAI MICRO Co., Ltd. (South Korea), and Sumitomo Electric Industries, Ltd. (Japan) and others.

Investment Funding 

The PTFE membranes market is witnessing investment activity driven by manufacturing expansions, capacity additions, and investments in advanced membrane and filtration technologies. Recent activity reflects continued interest in expanding production capabilities and strengthening membrane technology portfolios. Sartorius AG invested approximately USD 500 million in research and production infrastructure in 2025, including investments in membrane and filter production in Göttingen, Germany, and a new production site in Songdo, South Korea. Donaldson Company, Inc. also invested approximately USD 25 million to expand ePTFE membrane production capacity in Belgium. These investments indicate continued strategic interest in the market, with companies focusing on expanding manufacturing capabilities, strengthening supply capacity, and developing advanced PTFE membrane solutions.

Mergers & Acquisitions

Mergers/acquisitions in the PTFE membranes market for 2025 reflect growing strategic interest in advanced filtration, life sciences, and complementary membrane-related technologies, with buyers prioritizing technology capabilities, portfolio expansion, and access to high-growth pharmaceutical and biotechnology applications. Deal activity was supported by increasing demand for advanced filtration, bioprocessing, and laboratory technologies. One notable deal was Sartorius AG's acquisition of MatTek Corp., including Visikol Inc., from BICO Group AB, which strengthened Sartorius' life sciences portfolio and expanded its capabilities in advanced cell technologies.

Browse Adjacent Market: Membranes Market Research Reports & Consulting

See More Latest Membranes Reports:

Geomembranes Market by Type (HDPE, LDPE& LLDPE, PVC, EPDM, PP), Manufacturing Process (Extrusion, Calendering), Application (Mining, Water Management, Waste Management, Civil Construction, Others), Region - Global Forecast to 2031

Roofing Membranes Market by Membrane Type (Bituminous, Synthetic, Liquid Applied, Specialty Membranes), Function, End Use (Residential, Commercial, Industrial, Institutional/Public Infrastructure), and Region - Global Forecast to 2031

Waterproofing Membranes Market by Raw Material (Modified Bitumen, PVC, EPDM, TPO, Acrylic, Polyurethane, Polyurea, Other Raw Materials), Type (Liquid-Applied Membrane, Sheet Based Membrane), Usage (New Construction and Refurbishment), Application (Building Structure, Roofing, Walls, Roadways, Waste & Water Management, Other Applications), And Region - Global Forecast to 2031

Medical Membranes Market by Material (PSU, PES, PVDF, PTFE, PP, PAN, PA, Modified Acrylics), Process Technology (Ultrafiltration, Microfiltration, Nanofiltration), Application (Pharmaceutical Filtration, Hemodialysis, IV Fusion & Sterile Filtration, Membrane Oxygenator), and Region - Global Forecast to 2030

Microfiltration Membranes Market by Type (Fluorinated Polymers, Cellulosic, Polysulfones, Ceramic), pore size (>=0.1 micron, >=0.4 micron, >=0.8 micron), Filtration Mode (Cross flow, Direct flow), Applications - Global Forecast to 2029

About MarketsandMarkets™  

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

MarketsandMarkets™ SalesPlay is an AI-driven Revenue Intelligence Co-Pilot designed to help revenue teams prioritize the right accounts, identify critical changes early, and surface opportunities ahead of demand, so pipeline builds naturally and deals close with greater consistency.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:

Mr. Rohan Salgarkar

MarketsandMarkets™ INC.

1615 South Congress Ave.

Suite 103, Delray Beach, FL 33445

USA: +1-888-600-6441

Email: sales@marketsandmarkets.com

Visit Our Website: https://www.marketsandmarkets.com/

Research Insight: https://www.marketsandmarkets.com/ResearchInsight/ptfe-membrane-market.asp 

Content Source: https://www.marketsandmarkets.com/PressReleases/ptfe-membrane.asp 

SOURCE MarketsandMarkets

21%

more press release views with 

Request a Demo

Mixx Launches SxC™ Connector for High-Radix Scale-Up and Multi-Petabit Connectivity USA - English

NEWS PROVIDED BY

Mixx Technologies, Inc

Aug 31, 2026, 19:00 ET

SHARE THIS ARTICLE

One fiber connector technology, from the optical engine to the box edge. Live connector demonstration at SEMICON Taiwan.

SAN JOSE, Calif., Aug. 31, 2026 /PRNewswire/ -- Mixx Technologies, Inc., a US-based venture-backed deep-tech company building co-packaged optics for hyperscale AI infrastructure, today launched the SxC™ Connector, an optical connector for both the front plane and the backplane that terminates up to 24,576 fibers in a single rack unit. Mixx will hold live connector demonstrations at SEMICON Taiwan, booth #I2923, beginning September 2, 2026. 

sXc™ Expanded Beam Optical Connector

Mixx's first product to market is a fiber connector. The industry is moving toward co-packaged optics (CPO) in steps, through near-package optics, CPX, and similar socketed approaches. Each step needs more radix out of the box than existing connectors can deliver, and true CPO won't arrive without it. The connector determines how much optical I/O a box can carry. This layer decides whether optics solves the inference challenge at rack scale or only demonstrates it on a bench.

Inference has changed what a scale-up network needs. Mixture-of-experts and agentic workloads require every node to reach every other node with the lowest latency, and that all-to-all connectivity comes down to radix, the number of endpoints a single node can reach. Higher radix reduces the switching layers a packet crosses. Each layer removed takes its switches, transceivers, and cables with it, which means lower latency, lower aggregate power, and fewer components in the failure chain. 

Scale-out runs on a mature pluggable transceiver ecosystem, and the opportunity in scale-up is to extend that ecosystem rather than replace it. But the arithmetic arrives at the connector. A 400T switch brings thousands of fibers out of a single box, and pluggable transceivers cannot support that density at the front panel. Once optics move inside the box, fiber becomes the next bottleneck, and existing connector families do not easily support the density this generation requires. The inference challenge also means replacing an electrical backplane with an optical one, a requirement the mature ecosystem was never built to meet. 

One connector technology, inside the box and outside it

The SxC™ Connector is the first product in the SxC™ connector family, the system-level connectivity layer of the HBxIO™ platform. It uses the same core connector technology Mixx deploys across the optical signal chain. Mixx builds the optical engine and the connector, so it can optimize the interface from the start rather than negotiating it across multiple vendors.

Each connector scales up to 64 fibers, supporting both SMF and PMF in the same form factor depending on customer requirements. The same connector serves the front plane and the backplane, mounted at the faceplate or seated in a bulkhead. The industry workhorse, the MPO, carries 16 in the configuration typically deployed for this application, and the newer, more compact VSFF also usually carries 16. The SxC™ form factor does not change with lane rate or optical power, so the connector supports current and next-generation rates without redesign. By ganging up sixteen connectors within a bulkhead for the backplane, Mixx can terminate 1,024 fibers in less than 800 square millimeters, which is the figure of merit for a connector: fibers per square millimeter. Radix resolves to fiber count, and fiber count resolves to density at the box edge.

Twenty-four bulkheads bring a single OCP rack unit to 24,576 fibers. That is 4x the fiber density of MMC-VSFF, the highest-density connector platform qualified for deployment today, and what previously required a four-rack-unit enclosure with MMC connectors now fits in a single rack unit. That density is what makes the next step in CPO integration possible. Advanced packaging and cooling technologies have scaled what can sit inside a box faster than the front panel has scaled what can come out of it, and a box of co-packaged optical engines is limited today by the fiber at the box edge, not by the silicon inside. Bringing the fiber out through the edge of the box at this density removes that limit and puts multi-petabit connectivity from a single box within reach. 

Mixx is a member of the Expanded Beam Optics Multi-Source Agreement (EBO MSA), the multi-source agreement standardizing expanded-beam optical connectors, and the first connector specification is now in development. Expanded beam is where the industry is heading, and Mixx is contributing to that work while building for deployments happening now. Mixx's ferrule is glass rather than the plastic used in most connectors, which lets it handle the optical power levels that remote laser architectures and future multi-wavelength signals require. 

How the ferrule is made

Expanded-beam ferrules are conventionally assembled in series: starting with a V-groove substrate or molded plastic ferrules, individually placing fibers, dispensing epoxy, polishing, then actively aligning a lens before the assembly goes into a housing. That sequence limits fiber placement to a single array and reduces throughput and yield. Mixx forms the optical structures in a full wafer-scale integrated process using no exotic materials. The free-form optics, 3D waveguides, and 2D fiber holes are enabled by true wafer-scale processing, which allows fiber to be placed in a two-dimensional array to achieve high density and low loss.

Mixx is building an EBO connector that scales further than what is available today, so operators committing to optical infrastructure solutions now are committing to something that keeps scaling. Because the same core connector technology serves the optical engine, the external laser source (ELSFP), the backplane, and the front panel, volume aggregates across product lines instead of splitting across them. 

The ferrule was only half the problem. Cable assembly, the next step, has remained largely manual across the industry, and it is the constraint operators hit once ferrule supply is solved. Mixx is automating that step with robotic fiber assembly and automated visual inspection as part of the production pathway. The connector also supports passive fiber attach, drawing on years of pick-and-place optimization to remove the active-alignment step between lens and fiber that has historically limited yield and throughput.

"Every era of the data center has had a connector that carried it," said Vivek Raghuraman, CEO of Mixx Technologies. "MPO carried one generation, and VSFF carried the next, and each one arrived because the network behind it had changed shape. Inference has changed the shape again. What Mixx has built is not a denser version of the last connector. It is one ferrule technology that terminates the signal chain at the package, at the laser, at the backplane, and at the front panel, so the connectivity problem gets solved once instead of four times."

Demonstration

Mixx will show the connector at SEMICON Taiwan, booth #I2923, beginning September 2, 2026. The demonstration puts the hardware in visitors' hands, not on a slide. Attendees can seat and unseat a fully populated bulkhead by hand, watch the link come up on each cycle, and see the ferrule that makes it possible. 

About Mixx Technologies

Mixx Technologies, Inc. is a venture-backed deep-tech company founded by the team that commercialized many zero-to-one silicon photonics products. The company is solving the data-movement bottleneck for AI compute infrastructure through its HBxIO™ platform, a multi-terabit, ultra-high-radix co-packaged optical interconnect architecture enabling cloud service providers to deploy large-scale AI inference at the speed and efficiency hyperscale demands. Headquartered in San Jose, California, with R&D operations in India and Taiwan. Visit mixxtech.io.

Media Contact:

Ramya Barna

Head of Marketing & Investor Relations

Mixx Technologies, Inc

Info@mixxtech.io

SOURCE Mixx Technologies, Inc

21%

more press release views with 

Request a Demo

Solidion Technology, Inc. Appoints Three New Independent Directors to Its Board of Directors And Updates Its Board Committees

NEWS PROVIDED BY

Solidion Technology, Inc.

Aug 31, 2026, 18:57 ET

SHARE THIS ARTICLE

DALLAS, Aug. 31, 2026 /PRNewswire/ -- Solidion Technology Inc. ("Solidion" or the "Company") (Nasdaq: STI), an advanced battery technology solutions provider, today announced the appointment of Kimi L. Ellen, Mark N. Schwartz, and Dante W. Robinson as independent directors to its Board of Directors, effective August 31. Each of the new directors has been determined by the Board to be independent under the applicable listing standards of The Nasdaq Stock Market and applicable rules of the U.S. Securities and Exchange Commission.

Kimi L. Ellen

Mark N. Schwartz

Dante W. Robinson

The appointments strengthen the financial, audit, and governance expertise of Solidion's Board and its committees as the Company advances its battery materials and next-generation battery commercialization strategy. "Our entire organization is proud to welcome three new directors that bring a wealth of financial and governance experience to Solidion," said Jaymes Winters, Chief Executive Officer.

Kimi L. Ellen, CPA

Ms. Ellen is Managing Partner and Chief Executive Officer of Benford Brown & Associates, LLC, a full-service certified public accounting firm, and brings extensive expertise in audit, internal controls, financial reporting, risk assessment, and governance across public and private sector organizations. She is a Certified Public Accountant and an NACD Certified Director, and currently serves on the American Institute of CPAs Council and the Governmental Accounting Standards Advisory Council, among other board and committee roles. Ms. Ellen was named to Forbes' Top 200 CPAs in the U.S. in 2024 and 2025 and to "50 Women to Watch for Boards" in 2025. She holds a Bachelor of Science in Accountancy from the University of Illinois. Ms. Ellen will serve on the Board's Compensation Committee and the Audit Committee and has been determined to qualify as an "audit committee financial expert" as defined under SEC rules.

Mark N. Schwartz

Mr. Schwartz is a public and private company chief executive officer, chief financial officer, and director with extensive experience in corporate finance, initial public offerings, SEC reporting, mergers and acquisitions, and financial strategy across multiple industries. He currently serves as a director and Audit Committee Chair of Onfolio Holdings, Inc. (Nasdaq: ONFO) and as a director of Avicanna and the StartEngine Growth Tech Fund. Mr. Schwartz previously served on the board of directors of Starbucks Corporation. He holds a Master of Business Administration from Harvard Business School and a Bachelor of Arts from Claremont McKenna College. Mr. Schwartz will serve as Chair of the Compensation Committee and will also serve on the Board's Audit Committee and has been determined to qualify as an "audit committee financial expert."

Dante W. Robinson, CPA

Mr. Robinson is a financial and audit leader with more than three decades of experience in the finance industry and audit function, and currently serves as Chief of Internal Affairs at State Compensation Insurance Fund, one of California's largest workers' compensation insurers. He is a Certified Public Accountant, a qualified financial expert with experience serving as an Audit Committee Chair, and an NACD Board Leadership Fellow. Mr. Robinson holds a Bachelor of Science in Business Administration degree with an emphasis in accounting and finance from the University of California, Berkeley. Mr. Robinson will serve on the Board's Nominating and Governance Committee and the Audit Committee and has been determined to qualify as an "audit committee financial expert."

Board and Chair Composition

Following the appointments, Solidion's Board consists of seven directors, a majority number of whom are independent under Nasdaq listing standards.

Effective August 31, the Chairmanship of the Board Committees shall additionally be updated such that: 

Compensation Committee: Chaired by Mark Schwartz, whose qualifications are noted above.

Audit Committee: Chaired by Independent Board Member Karin-Joyce Tjon. Ms. Tjon has served as a director of the Company since the closing of its IPO. Ms. Tjon has served as a Director at Volcon, Inc. (NASDAQ: VLCN) and Kaleyra, Inc. (NYSE: KLR). Prior to Ms. Tjon's retirement in 2020, from July 2018 until May 2020 she served as Chief Financial Officer for Alorica, Inc. a multi-billion dollar customer service provider with over 100,000 employees worldwide. Ms. Tjon has more than 6 years of executive management level experience as a Chief Executive Officer for publicly listed companies and large privately held companies. Ms. Tjon was President and Chief Operating Officer for Scientific Games, Inc., responsible for their Gaming and Lottery divisions, and also served as Executive Vice President and Chief Financial Officer for Epiq Systems (NASDAQ: "EPIQ") where she was responsible for legal, governance and risk compliance as well as all areas of international corporate finance, including financial planning and analysis, accounting, SEC filings, tax planning, investor relations, and SAP support, and Ms. Tjon served at Alvarez & Marsal LLC, a leading global professional services firm, where Ms. Tjon served in several C-level posts guiding global clients through operational restructurings, business planning and execution, complex negotiations, financial audit and regulatory compliance issues, and technology issues. Ms. Tjon holds a Master of Business Administration from Columbia University's Graduate School of Business and a Bachelor's degree in specialized studies in Organizational Behavior from Ohio University.

Nominating & Governance Committee: Chaired by Independent Board Member John Davis. Since 2022, Mr. Davis has served as President of BTECH, Inc., a battery monitoring technology company. Prior to that role, from 2021 to 2022, Mr. Davis served as Chief Operating Officer of Primet Precision Materials, a nanoscission technology company producing lithium battery cathode. Prior to that role, from 2019 to 2020, Mr. Davis served as Chief Operating Officer of Global Graphene Group. Prior to that role, from 2015 to 2018, Mr. Davis served as Senior Vice President of Operations for BrightVolt, a solid state lithium battery technology company. Mr. Davis received a B.S. in Chemical Engineering and M.B.A. from the Illinois Institute of Technology.

About Solidion Technology, Inc.

Headquartered in Dallas, Texas with pilot production facilities in Dayton, Ohio, Solidion's (NASDAQ: STI) core business includes manufacturing of battery materials and components, as well as development and production of next-generation batteries for energy storage systems, including UPS systems serving the artificial intelligence (AI) data center market and electric vehicles for ground, aerospace, and sea transportation. Solidion holds a portfolio of over 385 patents, covering innovations such as high-capacity, silane gas free and graphene-enabled silicon anodes, biomass-based graphite, advanced lithium-sulfur and lithium-metal technologies.

For more information, please visit www.solidiontech.com or contact Investor Relations.

Forward-Looking Statements 

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Solidion Technology Inc., (NASDAQ: STI) (the "Company, " "Solidion," "we," "our" or "us") desires to take advantage of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and is including this cautionary statement in connection with this safe harbor legislation. The words "forecasts," "believe," "may," "estimate," "continue," "anticipate," "intend," "should," "plan," "could," "target," "potential," "is likely," "expect" and similar expressions, as they relate to us, are intended to identify forward-looking statements. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise, except as may be required by law.

SOURCE Solidion Technology, Inc.

21%

more press release views with 

Request a Demo

Genomma Lab Internacional Announces Long-Term Debt Transaction

NEWS PROVIDED BY

Genomma Lab Internacional, S.A.B. de C.V.

Aug 31, 2026, 18:59 ET

SHARE THIS ARTICLE

MEXICO CITY, Aug. 31, 2026 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), one of the leading pharmaceutical and personal care product companies in Mexico with an expanding international reach, announces that it has entered into a new MXN $1.0 billion long-term credit facility with Banamex, with a 3-year term.

The proceeds from this credit facility will be primarily used to refinance and prepay the Company's financial liabilities, including the repayment of an existing bank loan and upcoming maturities of the Company's outstanding certificates.

Antonio Zamora Galland, CFO, commented: "We appreciate Banamex's support through this long-term financing, which is part of Genomma Lab's strategy to optimize its debt maturity profile, strengthen the management of its working capital structure, and maintain a solid financial position that supports the growth of the business."

Jorge Rohana de la Vega, Corporate Director at Banamex, commented: "We are pleased to support Genomma Lab. This credit facility is part of our commitment to driving the growth of our clients and our strategy of being a partner to Mexican companies across all regions and sectors. In this way, we contribute to Mexico's economic development."

About Genomma Lab Internacional 

Genomma Lab Internacional, S.A.B. de C.V. is one of the fastest growing pharmaceutical and personal care products companies in Latin America. Genomma Lab develops, sells and markets a broad range of Premium branded products, many of which are leaders in the categories in which they compete in terms of sales and market share. The Company has a sound business model through a unique combination of a new product development process, consumer oriented marketing, a broad retail distribution network and a low‐cost, highly flexible supply chain operating model. For more information visit: www.genommalab.com

Genomma Lab's shares are listed on the Mexican Stock Exchange under the ticker "LABB" (Bloomberg: LABB:MM).

Note on Forward-Looking Statements

This report may contain certain forward-looking statements and information relating to the Company that reflect the current views and/or expectations of the Company and its management with respect to its performance, business and future events. Forward looking statements include, without limitation, any statement that may predict, forecast, indicate or imply future results, performance or achievements, and may contain words like "believe," "anticipate," "expect," "envisages," "will likely result," or any other words or phrases of similar meaning. Such statements are subject to a number of risks, uncertainties and assumptions. We caution you that a number of important factors could cause actual results to differ materially from the plans, objectives, expectations, estimates and intentions expressed in this presentation and in oral statements made by authorized officers of the Company. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of their dates. Risks and uncertainties include, but are not limited to: risks related to the impact of the COVID-19 global pandemic, such as the scope and duration of the outbreak, government actions and restrictive measures implemented in response, material delays, supply chain disruptions and other impacts to the business, or on the Company's ability to execute business continuity plans as a result of the COVID-19 pandemic, economic factors, such as interest rate and currency exchange rate fluctuations; competition, including technological advances, new products attained by competitors; challenges inherent in new product development; the ability of the Company to successfully execute strategic plans; the impact of business combinations and divestitures; manufacturing difficulties or delays, internally or within the supply chain; significant adverse litigation or government action, including related to product liability claims; changes to applicable laws and regulations, including tax laws; changes in behavior and spending patterns of purchasers of products and services; financial instability of international economies and legal systems and sovereign risk. A further list and descriptions of these risks, uncertainties and other factors can be found within the Company's related filings with the Bolsa Mexicana de Valores. Any forward-looking statement made in this release speaks only as of the date of this release. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

SOURCE Genomma Lab Internacional, S.A.B. de C.V.

21%

more press release views with 

Request a Demo

Greenway Reports First Quarter Fiscal 2027 Financial Results

NEWS PROVIDED BY

Greenway Greenhouse Cannabis Corporation

Aug 31, 2026, 17:10 ET

SHARE THIS ARTICLE

Greenway Greenhouse Cannabis Corporation Logo

KINGSVILLE, ON, Aug. 31, 2026 /PRNewswire/ -- Greenway Greenhouse Cannabis Corporation (CSE: GWAY) (OTCQB: GWAYF) ("Greenway" or the "Company"), a cultivator of high-quality greenhouse cannabis for the Canadian and international medical cannabis markets, today announced its unaudited financial results for the three months ended June 30, 2026 ("Q1 F2027).

All amounts expressed are in Canadian dollars.

During Q1 F2027, Greenway generated net revenue of $2.23 million, an increase of 38% compared with the same quarter in the previous year, while grams sold hit a record high of 2.33 million. The Company generated positive Adjusted EBITDA, and $36,778 of cash from operating activities.

Q1 Fiscal 2027 Highlights

Net revenue was $2,232,700, an increase of 38%, compared with $1,621,062 for the three months ended June 30, 2025.

Cash cost per gram sold improved to $.69, a 30% decrease from the previous year.

Average net sales for the quarter was $0.96 per gram, with a $1.30 per gram net sales average on sales excluding inventory associated with the discontinued cultivars that had previously been written down.

Record 2.33 million grams or grams equivalent sold, beating previous record high by 8%.

The Company generated $36,778 of cash from operating activities, compared with cash used of $865,538 in the comparative quarter.

Net loss and comprehensive loss was $659,893

Adjusted EBITDA was $47,900

Cash was $1,133,209 as at June 30, 2026.

Excluding amounts due to related parties, the Company had positive working capital of $4,537,711 as at June 30, 2026.

Greenway product can be found in all Canadian jurisdictions, as well as in four international markets.

"Q1 F2027 demonstrated Greenway's ability to deliver revenue growth and generate positive operating cash flow, even while working through a transition in our product mix," said Jamie D'Alimonte, Chief Executive Officer of Greenway. "Although the sale of legacy inventory affected pricing and margins, we remained Adjusted EBITDA positive. We believe the steps we have taken to refine our genetics, and product mix will better align our production with the markets and customers that offer the strongest long-term value, positioning Greenway to translate its operating capabilities into stronger and more consistent financial performance."

"Selling 2.33 million grams in the quarter - approximately 8% above our previous quarterly record - demonstrates the throughput Greenway's team and operating platform can support," said Carl Mastronardi, President of Greenway. "Achieving that volume while reducing cash cost per gram sold by 30% to $0.69 reflects the disciplined execution of our cultivation, processing and fulfillment teams. We will continue refining our production planning and operating processes while maintaining the product quality and consistency our customers expect."

Financial Summary

Net revenue for Q1 F2027 was $2,232,700, compared with $1,621,062 in Q1 F2026

Cost of sales before fair value adjustments was $1,969,262, compared with $1,136,239 in Q1 F2026, reflecting a significant increase in sales volume. Cash cost per gram sold improved by 30% from Q1 F2026 to $0.69.

Gross profit before fair value adjustments was $263,438, resulting in a gross margin before fair value adjustments decreased to 12%, primarily due to the lower average net sales price.

Operating expenses decreased to $632,571, with an operating loss of $353,706 for a net and comprehensive loss of $659,893, and a positive Adjusted EBITDA of $47,900.

Greenway generated $36,778 of cash from operating activities during the quarter, compared with cash used of $865,538 in Q1 F2026. The Company ended the quarter with cash of $1,133,209 and positive working capital of $4,537,711 when amounts due to related parties are excluded.

Product Mix and International Strategy

Since commencing international shipments in late 2024, Greenway has been able to expand its exposure to worldwide medical cannabis markets through strategic partnerships and cultivar development. To accomplish this, management has focused on premium cultivars, while maintaining disciplined cost controls. This has necessitated the retirement of certain legacy cultivars.

The lower average net selling price during Q1 F2027 primarily reflected sales of inventory associated with these now retired cultivars, with the inventory having been written down to net realizable value as at March 31, 2026 as part of the Company's year-end review of inventory values and production strategy.

Management believes the rebalancing of the companies' cultivar portfolio and production strategy will help position the company to be able to more rapidly expand into new jurisdictions that offer the strongest long-term value and develop long term strategic domestic and international partnerships.

Issuance of Shares

The Company, pursuant to its engagement letter dated June 4, 2024 with Abingdon Capital Corporation, an arm's length consultant (the "Consultant"), the Company has issued the Consultant and its assignees an aggregate of 478,404 common shares in the capital of the Company (the "Common Shares") at deemed prices between $0.15 and $0.18 per Common Share. The Common Shares were issued in satisfaction of a portion of the monthly work fee owed to the Consultant as consideration for the provision of corporate-finance advisory services. All Common Shares issued will be subject to a hold period of four months and a day from the date of issuance in accordance with applicable CSE policies and Canadian securities laws.

Copies of the interim financial statements for the three months ended June 30, 2026 (prepared in accordance with IFRS Accounting Standards ("IFRS")) and the related Management's Discussion and Analysis are available under the Company's profile on www.sedarplus.ca.

Non-IFRS Measures

Management uses a non-IFRS measure to assess the Company's performance. Non-IFRS measures do not have any standardized meaning under IFRS and are not a measure of financial performance under IFRS, and therefore, may not be comparable to similar measures presented by other companies. Please refer to the Company's Management's Discussion and Analysis for an explanation of the composition of Adjusted EBITDA, an explanation of how it provides useful information to an investor and a quantitative reconciliation to the most directly comparable financial measure under IFRS, all of which is hereby incorporated by reference in this press release.

Reconciliations of Non-IFRS Measures

The following table reconciles the non-IFRS measure to the most comparable IFRS measure for the three months ended June 30, 2026. This measure does not have any standardized meaning under IFRS and is not a measure of financial performance under IFRS, and therefore, may not be comparable to similar measures presented by other companies.

     For the three months ended June 30, 2026

Net Loss and Comprehensive Loss

$(659,893)

Amortization - Cost of sales

351,264

Fair value adjustment on sale of inventory

41,487

Fair value adjustment on growth of biological assets               

(56,914)

Amortization – Operating expenses

65,759

Interest and accretion expense

310,102

Interest income

(3,915)

Adjusted EBITDA

$  47,900

This press release shall not constitute an offer to sell or the solicitation of an offer to buy the securities in the United States nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "1933 Act"), or any state securities laws and may not be offered or sold in the United States unless registered under the 1933 Act and any applicable securities laws of any state of the United States or an applicable exemption from the registration requirements is available.

About Greenway

Greenway Greenhouse Cannabis Corporation is a federally licensed cultivator for the Canadian cannabis marketplace. Greenway is headquartered in Kingsville, Ontario, and leverages its agriculture and cannabis expertise in its aspiration to be a leading cannabis cultivator in Canada. More information can be found on Greenway.ca and updates can be followed on Instagram, X , Facebook, and LinkedIn.

The CSE has in no way passed upon the merits of the business of the Company and has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof.

Cautionary Note Regarding Forward-Looking Statements

This news release contains forward-looking statements that constitute forward-looking information (collectively, "forward-looking statements") within the meaning of applicable Canadian securities legislation. All statements in this news release that are not purely historical statements of fact are forward-looking statements, and the Company's beliefs, plans, expectations, future, strategy, objectives, goals and targets, the development of future operations, and orientations regarding the future as of the date of this news release. Although the Company believes that such statements are reasonable and reflect expectations of future developments and other factors which management believes to be reasonable and relevant, the Company can give no assurance that such expectations will prove to be correct. Forward- looking statements are typically identified by words such as: "believes", "expects", "aim", "anticipates", "intends", "estimates", "plans", "may", "should", "would", "will", "potential", "scheduled" or variations of such words and phrases and similar expressions, which, by their nature, refer to future events or results that may, could, would, might or will occur or be taken or achieved.

Forward-looking statements involve known and unknown risks, assumptions, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the forward-looking statements, and includes those risks described in the Company's final prospectus dated September 3, 2021, a copy of which is available under the Company's profile at www.sedarplus.ca. Forward-looking statements are made as of the date of this news release and, unless required by applicable law, the Company assumes no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those projected in these forward-looking statements

SOURCE Greenway Greenhouse Cannabis Corporation

21%

more press release views with 

Request a Demo

Astellas enters voluntary agreement with U.S. government supporting affordable access to medicines

NEWS PROVIDED BY

Astellas Pharma Inc.

Aug 31, 2026, 18:00 ET

SHARE THIS ARTICLE

– Agreement supports commitment to patient access, affordability and innovation –

TOKYO, Aug. 31, 2026 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that it has reached an agreement with the U.S. government that reflects our commitment to patient access, affordability and innovation, while reinforcing Astellas' longstanding commitment to the U.S. healthcare system.

Under the agreement, Astellas will take the following actions:

Lower the prices of medicines in Medicaid and establish pricing for future medicines aligned with other developed nations that reflect international market conditions, innovation, and patient value.

Further the resilience of the supply chain for important medicines by donating 25 kg of tacrolimus active pharmaceutical ingredient (API), the standard used to prevent solid organ transplant rejection, to the U.S. Strategic Active Pharmaceutical Ingredients Reserve (SAPIR).

Additional terms of the agreement are not being disclosed.

This agreement reflects our longstanding commitment to improving access for patients while continuing to invest in the research and development of innovative medicines.  We believe patients benefit most when affordability and innovation advance together, and we remain committed to working collaboratively with governments and healthcare stakeholders around the world to achieve both objectives for patients with serious unmet medical needs.

With U.S. headquarters in Northbrook, Ill., Astellas has a significant research, manufacturing, and economic footprint in the U.S. that supports patients, jobs and communities spanning from Massachusetts to California. Within the past ten years, Astellas has opened two new cutting-edge manufacturing facilities in the U.S., including a cell therapy manufacturing facility in Westborough, Mass., and a gene therapy manufacturing facility in Sanford, North Carolina. In 2024, Astellas also opened two new research centers – our West Coast Innovation Center in South San Francisco and the Astellas Life Sciences Center in Cambridge, Mass.

About Astellas

Astellas is a global life sciences company committed to turning innovative science into VALUE for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health. Through our research and development programs, we are pioneering new healthcare solutions for diseases with high unmet medical need. Learn more at www.astellas.com.

Cautionary Notes

In this press release, statements made with respect to current plans, estimates, strategies and beliefs and other statements that are not historical facts are forward-looking statements about the future performance of Astellas. These statements are based on management's current assumptions and beliefs in light of the information currently available to it and involve known and unknown risks and uncertainties. A number of factors could cause actual results to differ materially from those discussed in the forward-looking statements. Such factors include, but are not limited to: (i) changes in general economic conditions and in laws and regulations, relating to pharmaceutical markets, (ii) currency exchange rate fluctuations, (iii) delays in new product launches, (iv) the inability of Astellas to market existing and new products effectively, (v) the inability of Astellas to continue to effectively research and develop products accepted by customers in highly competitive markets, and (vi) infringements of Astellas' intellectual property rights by third parties. Information about pharmaceutical products (including products currently in development) which is included in this press release is not intended to constitute an advertisement or medical advice.

SOURCE Astellas Pharma Inc.

21%

more press release views with 

Request a Demo

CHICAGO AUTO SHOW: BEHIND THE WHEEL DEBUTS THIS FALL WITH EXPANDED TEST DRIVE EXPERIENCE USA - English

NEWS PROVIDED BY

Chicago Auto Show

Aug 31, 2026, 17:14 ET

SHARE THIS ARTICLE

OAKBROOK TERRACE, Ill., Aug. 31, 2026 /PRNewswire/ -- The Chicago Automobile Trade Association (CATA), producer of the Chicago Auto Show, is expanding its popular fall consumer test drive event with a new name, new branding and an even broader vehicle lineup. Formerly known as Chicago Drives Electric, Chicago Auto Show: Behind the Wheel, presented by ComEd, will take place Oct. 1-4, 2026, at the ComEd Building, 3 Lincoln Center in Oakbrook Terrace, Ill.

Chicago Auto Show: Behind the Wheel

The reimagined event reflects today's evolving automotive marketplace by expanding beyond electric vehicles to showcase the latest all-electric, hybrid, plug-in hybrid and traditional gas-powered vehicles. Consumers will have the opportunity to get behind the wheel to test drive the latest cars, trucks and SUVs from participating manufacturers, allowing them to compare different powertrain options in one convenient location.

"As the automotive industry continues to evolve, so has this event," said CATA President Jennifer Morand. "Chicago Auto Show: Behind the Wheel reflects the needs of today's consumers by offering the opportunity to experience a broad range of vehicles in one place. Whether you're interested in an EV, a hybrid or a traditional gas-powered vehicle, this event helps shoppers make informed decisions through hands-on experiences."

Knowledgeable product specialists will be onsite to answer questions, explain the latest vehicle technologies and help consumers determine which vehicles best fit their lifestyles and driving needs, helping shoppers make informed decisions. Participating brands include BMW, Chevrolet, Ford, Hyundai, Kia, Tesla, Toyota, VinFast and more, with a full listing of vehicles available for test drives to be announced closer to the event.

Attendees can register for a driving session at ChicagoAutoShow.com/BehindTheWheel. Tickets are $10 per driving participant, while non-driving guests may register to attend free of charge. Driving participants must be at least 18 years old and present a valid driver's license. Driving sessions are available on a first-come, first-served basis. Session times are Thursday, Oct. 1 (1-6 p.m.); Friday, Oct. 2 (8 a.m.-1 p.m. and 1-6 p.m.); Saturday, Oct. 3 (8 a.m.-1 p.m. and 1-6 p.m.); and Sunday, Oct. 4 (9 a.m.-1 p.m.).

In the next calendar year, the 2027 Chicago Auto Show public event will take place Feb. 13-21 at McCormick Place. The Media Preview dates are Feb. 11-12, and the First Look for Charity black-tie gala will be held the evening of Feb. 12. Tickets to the 2027 Chicago Auto Show and First Look for Charity gala will go on sale this fall at ChicagoAutoShow.com.

About Chicago Auto Show: Behind the Wheel 

Chicago Auto Show: Behind the Wheel is an interactive consumer test drive event produced by the Chicago Automobile Trade Association (CATA). The event showcases the latest all-electric, hybrid, plug-in hybrid and traditional gas-powered vehicles, giving consumers the opportunity to compare a variety of models and experience today's newest automotive technologies firsthand. For more information, visit ChicagoAutoShow.com/BehindTheWheel.

About the Chicago Auto Show

First staged in 1901, the Chicago Auto Show is the nation's longest running auto exposition in North America. The show is produced by Chicagoland's new-car dealer association, the Chicago Automobile Trade Association, which has staged the show since 1935. The 2027 public show is Feb. 13-21 at McCormick Place. For more information and the latest updates, visit ChicagoAutoShow.com.

About the Chicago Automobile Trade Association

Founded in 1904, the Chicago Automobile Trade Association is one of the nation's largest metropolitan dealer organizations. It is comprised of more than 420 franchised new-car dealers and an additional 150 allied members. The group's dealer members employ about 19,000 people in the metropolitan area. The association has produced the world-famous Chicago Auto Show since 1935. For more information, visit www.CATA.info.

SOURCE Chicago Auto Show

21%

more press release views with 

Request a Demo

Jack Henry Issues Statement on Response to Cybersecurity Incident

NEWS PROVIDED BY

Jack Henry & Associates, Inc.

Aug 31, 2026, 17:43 ET

SHARE THIS ARTICLE

MONETT, Mo., Aug. 31, 2026 /PRNewswire/ -- Jack Henry & Associates Inc.® (Nasdaq: JKHY) today issued the following statement on its response to a recent cybersecurity incident:

"Jack Henry recently detected a cybersecurity incident within a limited portion of our internal, non-production corporate environment. No client-facing systems, operating systems, core platforms, or daily processing services were accessed or disrupted, and they all remain secure and fully operational. We did not experience any system outages.

Protecting the financial institutions we serve and maintaining transparency are fundamental to everything we do at Jack Henry. We recognize and deeply regret any concern this incident may cause to our clients and their accountholders. Based on our investigation to date, personally identifiable information (PII) data for fewer than 10 clients was impacted. We have notified our more than 7,200 clients that an incident occurred, and we are working directly with the affected clients. We are offering two years of credit monitoring services to impacted financial institutions to provide to their accountholders.

Based on our investigation, the incident began with a sophisticated social engineering attack commonly known as vishing (voice phishing) initiated by a threat actor identified as ShinyHunters. Our security controls operated as intended to rapidly detect and contain the unauthorized activity. Upon detection, our teams immediately deployed specialized protocols to secure the network, isolate affected systems, and further heighten safeguards. We partnered with an independent third-party cyber forensics firm to support our investigation and response efforts and are actively collaborating with federal law enforcement.

This incident involved an extortion attempt, and we are not making any payment to the threat actor. We have determined that the incident is not financially material to the company.

Cyber incidents are an industry-wide reality, and our commitment to standing as a vigilant line of defense remains absolute. Through proactive monitoring and our rapid response framework, we effectively mitigated the threat and maintained operational integrity.

We deeply value the trust our clients place in Jack Henry and will continue to keep them informed as part of our commitment to transparency."

About Jack Henry & Associates, Inc.®

Jack Henry® (Nasdaq: JKHY) is a well-rounded financial technology company that strengthens connections between financial institutions and the people and businesses they serve. We are an S&P 500 company that prioritizes openness, collaboration, and user centricity – offering banks and credit unions a vibrant ecosystem of internally developed modern capabilities as well as the ability to integrate with leading fintechs. For 50 years, Jack Henry has provided technology solutions to enable clients to innovate faster, strategically differentiate, and successfully compete while serving the evolving needs of their accountholders. We empower more than 7,200 clients with people-inspired innovation, personal service, and insight-driven solutions that help reduce the barriers to financial health. Additional information is available at www.jackhenry.com. 

SOURCE Jack Henry & Associates, Inc.

21%

more press release views with 

Request a Demo